US Broker Ratings

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 35.8% Upside Potential Amidst Robust Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the Biotechnology industry, continues to capture investor interest with its innovative pharmaceutical products and promising development pipeline. Based in Dublin, Ireland,..

UnitedHealth Group (UNH) Stock Analysis: Navigating Healthcare Growth with a 1.67% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare plans industry, continues to capture investor attention with its robust market presence and strategic growth initiatives. As of the latest..

Haleon plc (HLN) Stock Analysis: Unpacking a 25.84% Potential Upside for Investors

Haleon plc (NYSE: HLN), a prominent player in the healthcare sector, has caught the eye of investors with its robust lineup of consumer healthcare products and a promising potential upside..

RadNet, Inc. (RDNT) Investor Outlook: Analyzing Growth Potential Amid a Competitive Healthcare Landscape

RadNet, Inc. (NASDAQ: RDNT) stands as a formidable player in the Healthcare sector, specifically within the Diagnostics & Research industry. With its headquarters in Los Angeles, California, RadNet has carved..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 16.35% Potential Upside with a Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE) remains a formidable player in the healthcare sector, known for its robust portfolio of biopharmaceutical products and pioneering vaccine development. With a market capitalization of $140.77..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotechnology Gem with 30.71% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is a compelling player in the biotechnology sector, particularly for investors looking for growth opportunities within the healthcare industry. With a market capitalization of $5.29..

Bausch + Lomb (BLCO) Investor Outlook: Navigating Through Growth and Challenges

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the eye health sector, continues to capture the attention of investors with its extensive portfolio of products and services. The Canadian-based..

Koninklijke Philips N.V. (PHG): Investor Outlook on Its 15.59% Upside Potential

Koninklijke Philips N.V. (PHG) offers a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $27.41 billion, this..

Neurocrine Biosciences, Inc. (NBIX): Investor Outlook with an 18% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands as a compelling figure in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a market capitalization of $14.28..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 14.5% Potential Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a stalwart in the medical devices sector, stands out in the healthcare industry with its innovative cardiovascular products aimed at treating advanced heart diseases. With..

Medtronic plc (MDT) Stock Analysis: Healthcare Giant Poised for a 7.96% Upside

Medtronic plc (NYSE: MDT), a leading name in the medical devices industry, is capturing investor attention with a potential upside of 7.96%, as suggested by recent analyst ratings. With a..

Elanco Animal Health (ELAN) Stock Analysis: A Closer Look at Growth Prospects Amidst Market Challenges

Elanco Animal Health Incorporated (ELAN) has emerged as a noteworthy player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $10.95..

Teva Pharmaceutical Industries (TEVA): Analyst Consensus Signals Nearly 29% Upside Potential

Investors eyeing opportunities in the healthcare sector should take a closer look at Teva Pharmaceutical Industries (NYSE: TEVA), an Israeli-based giant in the drug manufacturing industry specializing in both specialty..

Amgen Inc. (AMGN) Stock Analysis: Robust Revenue Growth and a Compelling 6.82% Upside

Amgen Inc. (NASDAQ: AMGN), a heavyweight in the healthcare sector, is a major player in the global drug manufacturing industry. With a market capitalization of $157.07 billion, Amgen continues to..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 17.74% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a specialty and generic drug manufacturer in the healthcare sector, stands as a significant player in the biotechnology landscape, focusing on chronic and life-threatening diseases...

Solventum Corporation (SOLV) Stock Analysis: Healthcare Innovator with a 19% Potential Upside

Solventum Corporation (SOLV), a significant player in the healthcare sector, is drawing attention with its expansive portfolio in medical instruments and supplies. With a market capitalization of $12.39 billion, Solventum’s..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with 22.51% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is capturing the attention of investors across the biotechnology sector with its impressive pipeline of transformative therapies targeting genetic diseases and cancers. Headquartered in Palo..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating Growth with a 6.88% Surge Amid a Robust Market Cap

HCA Healthcare, Inc. (NYSE: HCA), a titan in the healthcare sector with a market capitalization of $104.6 billion, has been making significant waves in the medical care facilities industry. Headquartered..

HealthEquity Inc. (HQY) Stock Analysis: Potential 26% Upside as Analysts Favor Buy Ratings

HealthEquity, Inc. (NASDAQ: HQY) is garnering considerable attention from investors, fueled by its robust market position in the healthcare sector and a promising forecast. As a leader in health information..

DaVita Inc. (DVA) Investor Outlook: Evaluating Growth Potential Amid a 16.50% Upside

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector, remains a focal point for investors interested in the medical care facilities industry. With a market capitalization of $9.24..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds